EI- Nile Co. for Pharmaceuticals and Chemical Industries Stock

Equities

NIPH

EGS38331C012

Pharmaceuticals

End-of-day quote Egyptian Exchange 06:00:00 2024-07-03 pm EDT 5-day change 1st Jan Change
69.06 EGP 0.00% Intraday chart for EI- Nile Co. for Pharmaceuticals and Chemical Industries 0.00% -16.90%
Sales 2022 877M 18.27M Sales 2023 1.01B 20.94M Capitalization 405M 8.44M
Net income 2022 89M 1.85M Net income 2023 119M 2.48M EV / Sales 2022 0.44 x
Net Debt 2022 26.21M 546K Net Debt 2023 191M 3.98M EV / Sales 2023 0.59 x
P/E ratio 2022
4 x
P/E ratio 2023
3.4 x
Employees -
Yield 2022
8.38%
Yield 2023
12.5%
Free-Float 21.83%
More Fundamentals * Assessed data
Dynamic Chart
EI- Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2024 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2023 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2022 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2021 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Announces Earnings Results for the Nine Months Ended March 31, 2021 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Announces Earnings Results for the Six Months Ended December 31, 2020 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2020 CI
Nile Pharmaceuticals and Chemical Industries Provides Earnings Guidance for the Year 2020 CI
The Nile Co. for Pharmaceuticals and Chemical Industries Announces Financial Results for the Six Months Ended December 31, 2019 CI
Nile Pharmaceuticals and Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2019 and Fourth Months Ended October 2019 CI
More news
1 month+0.45%
3 months-15.61%
6 months-16.90%
Current year-16.90%
More quotes
1 week
68.55
Extreme 68.55
71.79
1 month
65.02
Extreme 65.02
71.79
Current year
65.02
Extreme 65.02
103.99
1 year
37.00
Extreme 37
103.99
3 years
24.00
Extreme 24
103.99
5 years
15.70
Extreme 15.7
103.99
10 years
7.72
Extreme 7.72
103.99
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member - -
Chairman - -
Director/Board Member - -
More insiders
Date Price Change Volume
24-07-07 69.06 0.00% 1,321
24-07-04 69.06 0.00% 37
24-07-03 69.06 0.00% 691
24-07-02 69.06 0.00% 343
24-07-01 69.06 0.00% 1,250

End-of-day quote Egyptian Exchange, July 03, 2024

More quotes
El-Nile Co. For Pharmaceuticals and Chemical Industries specializes in developing, manufacturing and marketing pharmaceutical products primarily for the treatment of inflammatory, viral, infectious, cardiovascular, respiratory and gynecological diseases.
More about the company